A Randomised, Double-Blind, Placebo-Controlled Phase I Study to Assess the Tolerability, Safety, Pharmacokinetic, and Pharmacodynamic Properties of AZD6482, Alone and co-Administered With ASA [aspirin] , After Single Ascending Intravenous Doses to Healthy Male Subjects

Trial Profile

A Randomised, Double-Blind, Placebo-Controlled Phase I Study to Assess the Tolerability, Safety, Pharmacokinetic, and Pharmacodynamic Properties of AZD6482, Alone and co-Administered With ASA [aspirin] , After Single Ascending Intravenous Doses to Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jul 2008

At a glance

  • Drugs AZD 6482 (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 04 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top